- Tech stocks higher as ASX closes down.
- Deliveroo prepares for ASX debut.
- Smart crib to aid with baby sleep training.
Tech stocks closed higher but the S&P/ASX200 fell 0.78% for the day.
Healthcare imaging software company Pro Medicus extended its advance, adding 11.02%, following last week's announcement of a US$40M deal with US-based Intermountain Healthcare.
Bitcoin has dipped to just over US$34,800.
In tech news, London-based food delivery company Deliveroo has raised an additional US$180M, valuing the company at US$7BN, ahead of its London listing. CEO and founder Will Shu says the funding will go towards expanding into grocery deliveries and delivery-only kitchen sites.
Dominating the headlines, Australian biotech company Chimeric Therapeutics made its debut on the ASX, surging as much as 88% before closing 47.5% higher at AUD$0.375. The company is developing CAR-T, a cancer treatment based on cell therapies for solid tumours.
And a good night's sleep may be on the horizon for sleep deprived new parents following the launch of the Cradlewise smart crib. Priced at US$1500, the crib uses an inbuilt baby monitor and AI technology to learn a baby?s sleep patterns, bouncing and playing music to put them back to sleep.